Purine metabolism pathway enzyme

Purine metabolism pathway enzyme" is not a single molecular target but rather refers collectively to the group of **enzymes involved in the synthesis, salvage, interconversion, and degradation** of purines within cells. These include key enzymes such as **glutamine phosphoribosylpyrophosphate amidotransferase (GPAT)** for de novo synthesis; **adenosine phosphoribosyltransferase (APRT)** and **hypoxanthine–guanine phosphoribosyltransferase (HGPRT)** for the salvage pathway; and **adenosine deaminase**, **purine nucleoside phosphorylase**, and **xanthine oxidoreductase/xanthine oxidase** for catabolism[1][2][3][4][5]. These enzymes are essential for maintaining cellular pools of adenylate and guanylate nucleotides required for DNA/RNA synthesis, energy transfer, signaling processes, and cell division. Dysregulation or genetic defects in these pathways can lead to diseases such as gout or immunodeficiencies. However, "Purine metabolism pathway enzyme" is not a specific protein or gene but an umbrella term covering multiple distinct targets. For structured data purposes—such as drug discovery or biomarker identification—each individual enzyme should be considered separately. **Note:** This entry is too broad/vague to serve as a canonical therapeutic target name; it should be replaced by specific enzyme names like "Xanthine oxidoreductase," "Adenosylhomocysteinase," etc.[1][2][3]

Other names

Purine metabolic enzymesEnzymes of purine metabolismPurine biosynthetic enzymesPurine catabolic enzymes

Inhibition of xanthine oxidase to reduce uric acid production